Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Long-Term Investments (2018 - 2019)

Updated

Analysis

Grace Therapeutics (GRCE) Long-Term Investments (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 387.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 63.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 268.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.45 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 19,907.20
Sep 30, 2019 19,644.88
Jun 30, 2019 3.42 Mn
Mar 31, 2019 20,103.50
Dec 31, 2018 12.29 Mn
Sep 30, 2018 19,944.16
Jun 30, 2018 19,614.94
Mar 31, 2018 20,175.37
API Access

Grace Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=GRCE&period=max&api_key=YOUR_API_KEY